Edward Garmey

Edward Garmey has extensive experience in the biopharmaceutical industry. Edward is currently the Interim CMO at HiFiBiO Therapeutics, Consulting CMO at ModeX Therapeutics Inc, Consultant CMO at Tagworks Pharmaceuticals, GigaGen Inc, ImmunoMet Therapeutics, Inc., and Oncoheroes Biosciences, and Consultant Chief Medical Officer at Linnaeus Therapeutics and ImmuneSensor Therapeutics. In 2018, they founded CMO Consulting, Inc., a biopharmaceutical consulting firm. Prior to this, they were a Visiting Instructor at Harvard Medical School's Therapeutics Graduate Program from 2014-2018.

Edward Garmey received an AB from Harvard University and an M.D. from the Icahn School of Medicine at Mount Sinai.